Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects
NCT01641042
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
86
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Meningococcal
Interventions
BIOLOGICAL:
Meningococcal vaccine GSK134612
Sponsor
GlaxoSmithKline